EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Deciphering SCN2A : A comprehensive review of rodent models of Scn2a dysfunction

Katelin E J Scott iD, Maria Fernanda Hermosillo Arrieta iD, Aislinn J Williams

Epilepsia · 2025-12 · 66 (12) · 4624-4638

DOI: 10.1111/epi.18615 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epilepsia, online erschienen am 30.08.2025. Verfasst von Katelin E J Scott und 2 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Neuroscience Graduate Program, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: NAV1.2 Voltage-Gated Sodium Channel, Disease Models, Animal, Epilepsy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, U.S. Department of Defense, Roy J. and Lucille A. Carver College of Medicine, University of Iowa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SCN2A encodes for the alpha subunit of the voltage‐gated sodium channel Na V 1.2, which is involved in action potential initiation and backpropagation in excitatory neurons. Currently, it is one of the highest monogenetic risk factors for both epilepsy and autism spectrum disorder. However, SCN2A ‐related disorders manifest in a broad clinical neuropsychiatric spectrum, including distinct neurological and psychiatric disorders. This clinical heterogeneity presents challenges for mechanistic understanding and treatment development. SCN2A mutations are generally classified as either gain‐of‐function (GOF) or loss‐of‐function (LOF); however, many mutations do not perfectly align to this binary framework. SCN2A dysfunction alters neuronal excitability, channel kinetics, and synaptic transmission in various ways, resulting in multiple electrophysiological effects and both seizure and behavioral phenotypes that are influenced by developmental stage, brain region, genetic background, and sex. Although early lethality in GOF models limits behavioral characterization, LOF models broadly show patterns of learning impairments, altered sociability, and disrupted sensory processing. Still, behavioral and seizure phenotypes are often inconsistent even across models with similar or identical variants, suggesting that genetic modifiers, such as potassium channels, play a role in shaping disease outcomes. Overall, these findings suggest that SCN2A ‐related disorders involve complex gene–gene and gene–environment interactions, rather than only channel biophysics. Current therapeutic strategies include Clustered Regularly Interspaced Short Palindromic Repeat‐mediated transcriptional activation (CRISPRa), antisense oligonucleotides, and deep brain stimulation; however, they are limited due to variant specificity or age of intervention. This review highlights areas of convergence and conflict across models, emphasizing knowledge gaps, such as the limited availability of data on early development. Ultimately, it emphasizes the importance of investigating models across different developmental stages, using diverse genetic background strains, among other approaches, to encourage therapeutic innovation and enhance care for patients. We hope this work contributes to the emerging unifying framework that looks beyond the GOF and LOF binary in SCN2A ‐related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NAV1.2 Voltage-Gated Sodium ChannelDisease Models, AnimalEpilepsyAnimalsHumansMice

Stichwörter der Autor:innen

Nav1.2autismepilepsytherapeutics

Substanzen

NAV1.2 Voltage-Gated Sodium ChannelSCN2A protein, human

Autor:innen und Institutionen

  • Interdisciplinary Neuroscience Graduate Program, University of Iowa, Iowa City, Iowa, USA.
  • Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa, USA.
  • Department of Psychiatry, University of Iowa, Iowa City, Iowa, USA.
  • Iowa: Discovering Research Experiences and Mentorship Postbaccalaureate Program, University of Iowa, Iowa City, Iowa, USA.

ORCID-Profile: Katelin E J Scott, Maria Fernanda Hermosillo Arrieta

Förderung

  • NINDS NIH HHS
  • U.S. Department of Defense
  • Roy J. and Lucille A. Carver College of Medicine, University of Iowa
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Scott, K. E. J., Hermosillo Arrieta, M. F., & Williams, A. J. (2025). Deciphering SCN2A : A comprehensive review of rodent models of Scn2a dysfunction. Epilepsia, 66(12), 4624-4638. https://doi.org/10.1111/epi.18615

Vancouver

Scott KEJ, Hermosillo Arrieta MF, Williams AJ. Deciphering SCN2A : A comprehensive review of rodent models of Scn2a dysfunction. Epilepsia. 2025;66(12):4624-4638. doi:10.1111/epi.18615

BibTeX
@article{Scott2025,
  author = {Scott, Katelin E J and Hermosillo Arrieta, Maria Fernanda and Williams, Aislinn J},
  title = {Deciphering SCN2A : A comprehensive review of rodent models of Scn2a dysfunction},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {12},
  pages = {4624--4638},
  doi = {10.1111/epi.18615}
}
Kostenlos starten →